Annual Secretarial Compliance Report for the year 2024-25
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Lifesciences India Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's Listing Regulations. The report was prepared by CSB Associates, a practicing company secretary, and confirms that the company is broadly compliant with SEBI regulations and circulars. One minor deviation was noted: a director (Mr. TV Praveen) purchased equity shares just before the trading window closure on March 28, 2024, leading to a temporary PAN freeze by the depository to settle the share credit. No penalty was imposed, no actual trading occurred during the closed window, and management has been advised to avoid such instances. All other compliance areas — secretarial standards, policies, website disclosures, related party transactions, insider trading norms, and performance evaluation — were marked as fully compliant. No action was taken by SEBI or stock exchanges against the company during the year.
This is a routine annual compliance filing and does not signal any material concern for shareholders. The single deviation was a technical/administrative issue with no penalty or governance red flag, suggesting overall strong compliance practices by the company.